Ash pollen immunoproteomics: Identification, immunologic characterization, and sequencing of 6 new allergens - 01/03/14
Doi : 10.1016/j.jaci.2013.10.061
Salvador Mas, BSc a, María Torres, BSc a, María Garrido-Arandia, BSc a, b, Guillermo Salamanca, PhD a, c, Lourdes Castro, BSc a, c, Patricia Barral, PhD a, d, Ashok Purohit, MD, PhD e, Gabrielle Pauli, MD, PhD e, Rosalía Rodríguez, PhD a, Eva Batanero, PhD a, Rodrigo Barderas, PhD a 
, Mayte Villalba, PhD a
, Mayte Villalba, PhD a a Dpto. Bioquímica y Biología Molecular I, Universidad Complutense de Madrid, Madrid, Spain
b Centro de Biotecnología y Genómica de Plantas (UPM-INIA), Campus de Montegancedo, Pozuelo de Alarcón, Madrid, Spain
c ALK-Abelló, Madrid, Spain
d The Peter Gorer Department of Immunobiology, Guy's Hospital, King's College London, London, United Kingdom
e Service de Pneumologie, Hôpital Lyautey, Hopitaux Universitaires de Strasbourg, France
| This work was supported by the Ministerio de Ciencia e Innovación (grant no. SAF2008-04053), the Ministerio de Economía y Competitividad (grant no. SAF2011-26716), and the RIRAAF Network (grant no. RD12/0013/0015 from the ISCIII). M.T., G.S., and L.C. were fellows of the FPI program of the Ministerio de Ciencia e Innovación (Spain). P.B. was a fellow of the FPU program of the Ministerio de Educación. R.B. is a fellow of the Ramón y Cajal program of the Ministerio de Economía y Competitividad (Spain). |
|
| Disclosure of potential conflict of interest: M. Torres has been supported by one or more grants from Ministerio de Ciencia e Innovación (Spain). Patricia Barral has been supported by one or more grants from Ministerio de Educacion (Spain); has received support for travel from Ministerio de Educacion (Spain) and the European Academy of Allergology and Clinical Immunology; and is employed by King's College London, Oxford University, and Cancer Research UK. E. Batanero is employed by Universidad Complutense de Madrid (Spain). R. Barderas has been supported by one or more grants from Ministerio de Ciencia e Innovación (Spain) and is employed by Complutense University of Madrid. M. Villalba has been supported by one or more grants from the RIRAAF Network (grant no. RD12/0013/0015). The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 133 - N° 3
P. 923 - mars 2014 Retour au numéro
Article précédent
- Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
- Pranabashis Haldar, Christopher E. Brightling, Amisha Singapuri, Beverley Hargadon, Sumit Gupta, William Monteiro, Peter Bradding, Ruth H. Green, Andrew J. Wardlaw, Hector Ortega, Ian D. Pavord
- The expression of cannabinoid receptor 1 is significantly increased in atopic patients
- Mar Martín-Fontecha, Thomas Eiwegger, Tuomas Jartti, Ainoa Rueda-Zubiaurre, Kerstin Tiringer, Jefim Stepanow, Tuomo Puhakka, Beate Rückert, Silvia Ortega-Gutiérrez, María L. López-Rodríguez, Mübeccel Akdis, Cezmi A. Akdis, Oscar Palomares
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?